As emerging markets remain a focus area for growth for the pharmaceutical industry, Cegedim Strategic Data (CSD, a provider of integrated health care research, has conducted an international survey to benchmark medical representatives' quality across strategic countries of interest including the so-called BRIC nations (Brazil, Russia, India and China). To place these results in perspective, the survey also included the major markets of the USA, the top five in Europe and Japan. CSD says it will conduct this survey annually to analyze evolution in rep quality as assessed by physicians.
The study was conducted over the first quarter of 2010 and used four criteria: Objective and Ethical Behavior, Quality of Medical Information Provided, Professional Relationship and Presentation Useful and Adapted to the physicians' practice.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze